Cargando…
AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ
OBJECTIVE: Peroxisome-proliferator–activated-receptor-γ (PPARγ) acts as a transcriptional regulator of multiple genes involved in glucose and lipid metabolism. In vitro studies showed that activated PPARγ suppresses AT1R-gene expression and vice versa. However, it has not yet been determined in vivo...
Autores principales: | Tiyerili, Vedat, Becher, Ulrich M, Aksoy, Adem, Lütjohann, Dieter, Wassmann, Sven, Nickenig, Georg, Mueller, Cornelius FH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667017/ https://www.ncbi.nlm.nih.gov/pubmed/23374104 http://dx.doi.org/10.1186/1475-2840-12-30 |
Ejemplares similares
-
Atheroprotective effects of 17β-oestradiol are mediated by peroxisome proliferator-activated receptor γ in human coronary artery smooth muscle cells
por: Jehle, Julian, et al.
Publicado: (2020) -
Impact of peroxisome proliferator-activated receptor γ on angiotensin II type 1 receptor-mediated insulin sensitivity, vascular inflammation and atherogenesis in hypercholesterolemic mice
por: Tiyerili, Vedat, et al.
Publicado: (2015) -
Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 (VKORC1L1) Inhibition Induces a Proliferative and Pro-inflammatory Vascular Smooth Muscle Cell Phenotype
por: Aksoy, Adem, et al.
Publicado: (2021) -
Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1(−/−) LDLr(−/−) double knockout mice
por: Jehle, Julian, et al.
Publicado: (2017) -
CHA(2)DS(2)-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator
por: Kavsur, Refik, et al.
Publicado: (2021)